NCT07031297Recruiting
Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
Upper Body Subcutaneous Adipose Tissue Outflow Response to a Meal
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to understand the specific outflow and difference between normal weight and volunteers with obesity of upper body subcutaneous adipose tissue in response to a mixed meal challenge by site specific cannulation of the superior epigastric vein. We will characterize the exosome signatures in response to a meal and compare to the exosome signature of arterialized venous plasma samples.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 23 May 2025
- Start date
- 5 May 2026
- Primary completion date
- 31 May 2028
- Lead sponsor
- Mayo Clinic
- Diseases
- Obesity
- NCT number
- NCT07031297
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 5 May 2026 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants taking medications know to affect blood flow (statins, β-blockers) or fatty acid or adipose tissue metabolism (TZDs, high dose fish oil supplements)
Other illness
- Diabetes, history of cardiovascular disease
- Allergy to lidocaine
Other
- Post-menopausal women
- Pregnant
Who the study is looking for
- All women must be premenopausal
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.